Is Viyash Scientific Limited a good investment? Viyash Scientific Limited (VIYASH.NS) is currently trading at 294.15 INR. Market analysts have a consensus price target of 300.00 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 66.76. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Viyash Scientific Limited is expected to release its next earnings report on Aug. 12, 2026. The market consensus estimate for Forward EPS is 13.30.
No, it does not currently pay a dividend.
Viyash Scientific Limited is classified as a Stock.
The next earnings date is projected to be Aug. 12, 2026. The company currently has a trailing EPS of 4.01.
Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
| Year | Total Dividends |
|---|---|
| ▸2021 |
0.50 INR
|
| Oct. 21, 2021 | 0.5000 |
| ▸2019 |
0.20 INR
|
| Sept. 28, 2019 | 0.2000 |
| ▸2017 |
0.20 INR
|
| Dec. 4, 2017 | 0.2000 |
Community Discussion